 CAMBRIDGE, England, BOSTON--BUSINESS WIRE--Bicycle Therapeutics plc NASDAQ: BCYC, a biotechnology company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide Bicycle technology, today announced that management will participate in a fireside chat at the Morgan Stanley 20th Annual Global Healthcare Conference on September 13th, 2022 at 10:00 a.m. ET. A live webcast of the fireside chat will be accessible in the Investors and Media section o 